Stanford Center for Biomedical Ethics (SCBE) has received a grant for expanding the Center for Ethical, Legal and Social Implications (ELSI) and Center for Resources and Analysis (CERA).
Abelacimab, a factor XI inhibitor, demonstrated a 62–69% reduction in major bleeding compared to rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk, with comparable safety and ...
In the future, a person’s own cells could be used in a 3D printer to make bioprinted cartilage to help repair damaged joints. Brian Eames is a scientist and professor ...